Silence Therapeutics
SLN
7 hedge funds and large institutions have $39.4M invested in Silence Therapeutics in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
17% more funds holding
Funds holding: 6 → 7 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.35% less ownership
Funds ownership: 2.53% → 2.18% (-0.35%)
30% less capital invested
Capital invested by funds: $56.4M → $39.4M (-$17.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$1.06M |
| 2 |
SG Americas Securities
New York
|
+$174K |
| 3 |
Morgan Stanley
New York
|
+$25.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$7.53M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$1.04M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $14.4M | – | – | – |
|
|
LOAMU
2
Lombard Odier Asset Management (USA)
New York
| $10.7M | -$7.53M | -314,993 | -34% |
|
3
Adage Capital Partners
Boston,
Massachusetts
| $9.16M | – | – | – |
|
|
CCM
4
Consonance Capital Management
New York
| $3.73M | -$1.04M | -43,435 | -20% |
|
|
5
William Blair & Company
Chicago,
Illinois
| $911K | +$1.06M | +44,444 | New |
|
|
6
SG Americas Securities
New York
| $275K | +$174K | +7,300 | +135% |
|
|
7
Morgan Stanley
New York
| $218K | +$25.1K | +1,050 | +11% |
|
SLN Hedge Fund Activity: Q3 2021 in Review
7 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Silence Therapeutics (SLN) for Q3 2021, worth a combined $39.4M — down 30% from $56.4M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SLN positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was William Blair & Company, opening a new position worth an estimated $1.06M. The largest seller was Lombard Odier Asset Management (USA), cutting an estimated $7.53M.
- 7 institutional investors held Silence Therapeutics (SLN) as of Q3 2021, up from 6 in Q2 2021.
- Funds reported $39.4M of Silence Therapeutics stock for Q3 2021, down 30% quarter-over-quarter.
- 1 fund opened new Silence Therapeutics positions in Q3 2021 and 0 closed out, a net change of +1 holder.
- The largest Silence Therapeutics buyer in Q3 2021 was William Blair & Company, an estimated $1.06M added.
- The largest Silence Therapeutics seller in Q3 2021 was Lombard Odier Asset Management (USA), an estimated $7.53M sold.
Based on aggregated 13F filings for Q3 2021.